Policy for E Waste Management

Policy for E Waste Management

Policy for E Waste Management
Approved Board of Management on 09th July 2022
Next Review 2025-26
  1. Short Title & Commencement
    1. This Policy shall be called “Policy for E Waste Management” of the University.
    2. This Policy shall come into force from the date of approval of the Board of Management of the University.
    3. Unless otherwise specifically provided in this Policy, pronouns in masculine, feminine and neuter genders shall be construed to include any other gender, and words in the singular form shall be construed to include the plural and vice versa.
  2. For environmentally sound management of e-waste, the University shall take all steps required to ensure that e-waste is managed in a manner which shall protect health and environment against any adverse effects, which may result from such e-waste.
  3. For the purpose of this policy, the e-waste by and large includes electrical and electronic equipment, Electrical & Electronic Tools, Medical Devices, Laboratory Instruments.
  4. Once the duly constituted Condemnation Committee of the University, after following the due process as prescribed under the ‘Policy for Condemnation and/or Disposal of Assets’ declares any of the electrical and electronic equipment/ electrical & electronic tools/ medical devices/ laboratory instruments, as ‘condemned’ thereafter the condemned item shall be treated as E-Waste.
  5. Under no circumstances, condemned material/equipment/machinery should remain in use once the condemnation proceedings have been finalized.
  6. The Material Management Department shall get the e-waste removed from the concerned constituent unit(s) to the place earmarked for their temporary storage.
  7. The e-waste shall be disposed off by the University in accordance with the ‘Policy for Condemnation and/or Disposal of Assets’ and the prevalent laws on the subject.
  8. Precautions for Disposal
    1. Hazardous items should be handled with utmost care and must be dealt with in accordance with the provisions of Environment Protection Act 1986 so that no claim is established against the University in any court of law.
    2. Specific precaution for disposal of “Medical Devices” should be taken. Similarly, items relating to lab equipment and IT materials, stringent caution must be taken when disposing of obsolete equipment and ensure that the disposal will not lead to prosecution or payment of damages.
    3. When disposing of any material/equipment/machinery other than by destruction or scrapping, the following stringent precautions should be taken:
      1. Material/equipment/machinery must be checked to ensure they are safe at the time of sale or disposal.
      2. A signed receipt must be obtained from the recipient (the owner/in-charge) accepting responsibility for the use only in accordance with the manufacturers’ instructions and for ensuring further regular checking and maintenance.
      3. If a decision is made to scrap the material or equipment, sufficient precaution should be taken to ensure that there should be no risk to anyone while disposing of them nor to anyone who may subsequently try to reuse them.
      4. All equipment sent for scrapping must be rendered unusable by severe physical damage thus preventing repair and subsequent resale or reuse.
      5. Disposal should be carried out by authorized staff who will be aware of the Environmental and Safety Regulations applying to Special Waste.
      6. The department using the item must inform the Condemnation Committee of any known hazardous substances contained in the item. These items are classified as Special Waste and as such must be dealt with in accordance with the Environmental Protection Act of 1986.

    9. The University reserves the right to interpret, alter, amend, modify, cancel or withdraw any provision mentioned herein above in this Policy without any notice. However, the University shall adhere to the rules of the regulatory bodies governing e-waste management.

    Notwithstanding anything stated in this Policy, for any unforeseen issues arising, and not covered by this Policy, or in the event of differences of interpretation, the Vice-Chancellor may take a decision and the decision of the Vice-Chancellor shall be final and binding.

   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.